CLINICAL_TRIALS ClinicalTrials.gov record update

An Open, Single-Arm, Single-Center Clinical Study Assessing the Safety and Efficacy of BCMA-CD19 Targeted Chimeric Antigen Receptor T-Cell Therapy in Multiple Refractory Autoimmune Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06794008
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:39.963050+00:00
Published At: 2025-04-02T00:00:00+00:00
Record Updated At: 2025-04-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-04-02"
protocolSection.identificationModule.nctId: "NCT06794008"
protocolSection.identificationModule.officialTitle: "An Open, Single-Arm, Single-Center Clinical Study Assessing the Safety and Efficacy of BCMA-CD19 Targeted Chimeric Antigen Receptor T-Cell Therapy in Multiple Refractory Autoimmune Diseases"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.